Annual Review Course (2019)

Austin, TX US
May 31, 2019 to June 2, 2019

In preparation for the American Board of Urology (ABU) Qualifying (Part 1) Examination, residents need to have basic urologic knowledge to prepare them for the ABU examinations. To fulfill this need, the American Urological Association (AUA) developed this course to disseminate current urologic knowledge. This course is also of interest to practicing urologist preparing for the ABU Knowledge Assessment as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.


Attendees can choose between three options:

1. Live Course*

2. Bundle (Live + Webcast) Most Popular Option!*

3. Webcast Only

 

*Syllabus (hard copy)  is only available for Live or Bundle purchase options

 

Select our most popular option, the Annual Review Bundle, for access to the in-person course and the webcast.

Early Bird Registration- On or before April 19, 2019

 

Live Course Only

Bundle (Live + Webcast)*

Webcast Only

Hard Copy Syllabus**

Now through May 10, 2019

Member$920$1220$920$205
Non-Member$1150$1450$1150
Member Resident/Allied$510$660$510
Non-Member Resident/Allied$635$785$635

 

Standard Registration- On or after April 20, 2019

 

 

Live Course Only

Bundle (Live + Webcast)*

Webcast Only

Hard Copy Syllabus**

Now through May 10, 2019

Member$1150$1450$920$205
Non-Member$1435$1735$1150
Member Resident/Allied$635$785$510
Non-Member Resident/Allied$790$940$635

*Includes registration for Annual Review Live Course and Webcast.

**Hard Copy syllabus is only for purchase for those attending the Live Course. No hard copy syllabus will be shipped.

Webcast will be available to view on Wednesday, June 5, 2019.

 

Target Audience

  • Residents
  • Urologists

Learning Objectives

At the conclusion of this course, participants will be able to:

  1. Apply basic, generally accepted urological practices for superior patient care.
  2. Demonstrate core knowledge of urology necessary for Part I of the American Board of Urology (ABU) qualifying examination and for the ABU Knowledge Assessment.
  3. Utilize AUA Guidelines for appropriate patient evaluation and management.
Course summary
Course opens: 
11/15/2018
Course expires: 
06/02/2022
Event starts: 
05/31/2019 - 7:00am EDT
Event ends: 
06/02/2019 - 5:00pm EDT
Price:
$1,435.00
Rating: 
0

Friday, May 31, 2019

6:30 a.m. Registration/Breakfast
7:30 a.m.Introduction 
Howard B. Goldman, MD, FACS and Wade J. Sexton, MD

Anatomy and Embryology

7:45 a.m. Howard B. Goldman, MD, FACS 
  • Applied Anatomy
  • Embryology

Penile and Urethral Cancer

9:30 a.m.Robert G. Uzzo, MD
  • Epidemiology
  • Diagnosis and Staging
  • Imaging and Treatment
10:15 a.m.Break

Bladder Cancer

10:30 a.m.Michael A. O'Donnell, MD 
  • Epidemiology, Anatomy, Diagnosis and Imaging
    • Treatment of NMIBC/Superficial Disease Management
    • Bladder Cancer Test Questions
11:40 a.m.Angela M. Smith, MD, MS, FACS      
  • Staging and Risk Stratification of Muscle Invasive Bladder Cancer
  • Multidisciplinary Treatment including Radical Cystectomy, Lymphadenectomy, Peri-Operative Chemotherapy and Chemoradiation Therapy
  • Metabolic Derangements that Occur with Diversions
  • Other Bladder Sparing Treatments
  • Treatment of Metastatic Disease
  • Bladder Cancer Test Questions
1:00 p.m.Lunch

Prostate Cancer

2:00 p.m.Adam S. Kibel, MD 
  • Diagnosis and Screen, Staging, Imaging (including PSA Screening Controversies)
  • Treatment of Localized Cancer (U.S. Stages A and B), Watchful Waiting, Radiation, Interstitial Irradiation, Surgery, Cryosurgery, and Hormonal Therapy)
  • Treatment of Advanced Cancer (U.S. Stages C and D) and Treatment of Radiaiton Failure
  • DVT Prophylaxis

BPH

3:10 p.m.Claus G. Roehrborn, MD
  • Evaluation
  • Medical Management
  • Surgical Management
3:45 pmBreak

Renal and Ureteral Tumors

4:00 p.m.Robert G. Uzzo, MD
  • Epidemiology, Anatomy, Diagnosis and Imaging (Including Evaluation of Renal Masses)
    • Treatment of Localized Disease (including Role of Partial Nephrectomy)
    • Treatment of Metastatic Disease
    • Transitional Cell Carcinoma

Erectile Dysfunction

5:15 p.m.John P. Mulhall, MD
  • Physiology of Erection, Pathophysiology of Erectile Dysfunction
  • Evaluation and Management of Erectile Dysfunction
  • Pathophysiology, Evaluation and Management of Priapism Pathophysiology, Evaluation and Management of Peyronie's Disease
6:15 p.m.Meeting Adjourns for the Day

Saturday, June 1, 2019

6:30 a.m.  Breakfast
7:00 a.m.

Gary Lemack, MD
Exam Overview, Test Taking Logistics, and ABU Process

Pediatric Urology

7:30 a.m.Andrew J. Kirsch, MD 
Congenital Urinary Tract Abnormalities 
  • UPJ Obstruction, UVI Obstruction (megaureter)
  • Ureteroceles
  • Cystic Kidney Disease
  • Posterior Urethral Valves
  • Prune Belly Syndrome
  • Vesicoureteral Reflux
8:15 a.m.Armando J. Lorenzo, MD, MSc, FRSCS, FAAP, FACS 
Pediatric Urinary Incontinence and Bladder Disorders 
  • Voiding Dysfunction and Neurogenic Bladder 
  • Developmental Anomalies of the Bladder
  • Urinary Tract Infection and Secondary Reflux
  • Management of Neurogenic and Non-Neurogenic Bladder
  • Pediatric Metabolic Stones
9:00 a.m.Andrew J. Kirsch, MD
Disorders of the Genitalia/Scrotum
  • Disorders of Sexual Differentiation
  • Hypospadias
  • Undescended Testicle
9:30 a.m.Armando J. Lorenzo, MD 
Pediatric Urological Oncology 
  • Wilm's Tumor and other Renal Tumors
  • Rhabdomyosarcoma
  • Neuroblastoma
  • Testis Tumors
10:15 a.m.Break
10:30 a.m.Pediatric Review Questions
Andrew J. Kirsch, MD and Armando J. Lorenzo, MD, MSc, FRCSC, FAAP, FACS 

GU Radiology

10:45 a.m.Nicole M. Hindman, MD
  • Basics of MR, CT, US, VCUG
  • Solid Cystic Renal Masses (CT and MR)
  • Transitional Cell Carcinoma
  • Prostate MR
  • Adrenal Imaging
  • Scrotal Imaging
  • Retroperitoneal Tumors
  • Radiation Basic Principles
12:00 p.m.Lunch

Urinary Tract Infection

1:00 p.m.Michel Y. Pontari, MD

Infection and Inflammation

2:00 p.m.Daniel A. Shoskes, MD
  • Interstitial Cystitis
  • Sexually transmitted Diseases (Gonorrhea, Chlamydia, AIDS and others)
2:45 p.m.Break

Renal Medicine

 

3:00 p.m.Daniel A. Shoskes, MD
  • Renal Transplantation
  • Renal Vascular Disease
  • Renal Physiology (including Fluid and Electrolytes)

Adrenal

4:30 p.m.

Steven J. Shichman, MD

  • Epidemiology, Diagnosis and Imaging (including Cushings, Hyperaldosteronism, Pheochromocytoma, Cancer and the Incidentally Found Adrenal Mass)
  • Management (including Pheochromocytoma, Cancer, Hyperaldosteronism, Incidentaloma, and Metastatic Disease)
5:15 p.m.Meeting Adjourns for the Day

Sunday, June 2, 2019

6:30 a.m.Breakfast

Female Urology, Urodynamics and Neurology

7:00 a.m.Stephen R. Kraus, MD    
Neurourology
7:45 a.m.Urodynamics Tracing Review 
Stephen R. Kraus, MD and Howard B. Goldman, MD, FACS
8:15 a.m.Howard B. Goldman, MD 
  • Overactive Bladder/Urgency Incontinence 
  • Stress Urinary Incontinence
  • Pelvic Organ Prolapse
  • Vaginal Masses/Urethral Diverticulum
  • Urinary Fistula
9:30 a.m.Break

Urolithiasis

9:45 a.m.Sara L. Best, MD
  • Epidemiology, Pathophysiology
  • Evaluation and Medical Management

Laparoscopy

10:45 a.m.Steven J. Shichman, MD
  • Physiology and Complications

Urolithiasis (cont.)

11:15 p.m.Sara L. Best, MD
  • Surgical Management of Stone Disease
12:00 p.m.Lunch

Testicular Tumors

1:00 p.m.Wade J. Sexton, MD 
  • Epidemiology, Diagnosis, Staging and Imaging (including the Role of Makers and CIS)
  • Treatment of Seminoma
  • Treatment of Non-Seminomatous Germ Cell Tumors (including Controversy Regarding Stage A Management, Risk Factors for Recurrence, Algorithms for Stages A, B, and C)
2:15 p.m.Break

Urologic Trauma

2:30 p.m.Jay Simhan, MD
  • Renal and Uretral Trauma: Evaluation and Management
  • Bladder and Urethral Trauma: Evaluation and Management
  • Genital Trauma: Evaluation and Management
  • Urtheral Stricture Disease

Infertility

3:30 p.m.Paul J. Turek, MD
  • Physiology and Pathophysiology of Male Reproduction
  • Evaluation of the Infertile Male
  • Treatment fo the infertile Male (Surgical and Non-surgical)
  • Hypogonadism
  • Testosterone Replacement
5:00 p.m.Meeting Adjourns
Hyatt Regency Austin
208 Barton Springs
Austin, TX 78704
United States

For live course and live course + webcast registrants- see below hotel information. For webcast only registrants, your purchase is for virtual access to this course only.


To hold a reservation, a major credit card number must be provided.
$199 single/double occupancy.  Make your reservation online or call 512-477-1234.  Reference the AUA Annual Review Course when making your reservation to receive the special group rate.

Cut-off Date: Thursday, May 9, 2019. Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.

Check-in: 4 p.m.
Check-out: 11 a.m.

 

Tourism

There is never a dull moment in Austin, and Hyatt Regency Austin is close to everything. Take advantage of the Lady Bird Lake location situated along the Ann and Roy Butler Hike-and-Bike Trail, perfect for an evening run or biking with Austin’s B-cycles. Head over to 6th Street attractions, Rainey street entertainment and do some shopping down South Congress Street. There are endless dining options to enjoy in Austin with excellent barbecue, Tex-Mex and food trucks. 

Course Director(s)

Howard Goldman, MD, FACS

has a financial relationship (Independent contractor) with Medtronic;.
has a financial relationship (Independent contractor) with Laborie;.
has a financial relationship (Independent contractor) with Nuvectra;.
has a financial relationship (Independent contractor) with Neurostim;.
has a financial relationship (Independent contractor) with Galvani;.
has a financial relationship (Independent contractor) with allergan;.
has a financial relationship (Independent contractor) with Boston Scientific;.
has a financial relationship (Independent contractor) with NewUro;.
has a financial relationship (Other) with Medtronic;.
has a financial relationship (Independent contractor) with Bluewind;.
has a financial relationship (Independent contractor) with Nuvectra;.
has a financial relationship (Independent contractor) with Neurostim;.
has a financial relationship (Independent contractor) with Galvani;.
has a financial relationship (Independent contractor) with Medtronic;.
has a financial relationship (Independent contractor) with Laborie;.
has a financial relationship (Other) with Medtronic;.
has a financial relationship (Independent contractor) with Bluewind;.
has a financial relationship (Independent contractor) with allergan;.
has a financial relationship (Independent contractor) with Boston Scientific;.
has a financial relationship (Independent contractor) with NewUro;.

Wade Sexton, MD

has no relevant financial relationships to disclose at this time.
Faculty(s)

Sara Best, MD

has a financial relationship (Independent contractor) with American Urological Association;.
has a financial relationship (Independent contractor) with American Urological Association;.

Nicole Hindman, MD

has no relevant financial relationships to disclose at this time.

Adam Kibel, MD

has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with ConfirmMDx;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with ConfirmMDx;.
has a financial relationship (Other) with Bristol-Myers Squibb;.
has a financial relationship (Independent contractor) with Insight Diagnositics;.
has a financial relationship (Other) with Bristol-Myers Squibb;.
has a financial relationship (Independent contractor) with Insight Diagnositics;.
has a financial relationship (Independent contractor) with Blue Earth Diagnositics;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with Blue Earth Diagnositics;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Profound;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Profound;.

Andrew Kirsch, MD

has no relevant financial relationships to disclose at this time.

Stephen Kraus, MD

has a financial relationship (Independent contractor) with Avadel;.
has a financial relationship (Other) with Laborie;.
has a financial relationship (Independent contractor) with Allergan;.
has a financial relationship (Independent contractor) with Allergan;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with InCube;.
has a financial relationship (Independent contractor) with InCube;.
has a financial relationship (Independent contractor) with Avadel;.
has a financial relationship (Other) with Laborie;.

Armando Lorenzo, MD, FAAP, FACS, FRCSC, MSC

has no relevant financial relationships to disclose at this time.

John Mulhall, MD

has a financial relationship (Independent contractor) with the journal of sexual medicine;.
has a financial relationship (Independent contractor) with vault;.
has a financial relationship (Independent contractor) with the journal of sexual medicine;.
has a financial relationship (Independent contractor) with vault;.

Michael O'Donnell, MD

has a financial relationship (Independent contractor) with Tocogen;.
has a financial relationship (Independent contractor) with Fidia Pharmaceuticals;.
has a financial relationship (Independent contractor) with Photocure;.
has a financial relationship (Other) with Roche/Genentech;.
has a financial relationship (Independent contractor) with Telesta;.
has a financial relationship (Other) with Medical Enterprises;.
has a financial relationship (Stock) with Theralase;.
has a financial relationship (Independent contractor) with Cold Genesis;.
has a financial relationship (Independent contractor) with Medical Enterprises;.
has a financial relationship (Independent contractor) with Theralase;.

Michel Pontari, MD

has a financial relationship (Independent contractor) with MicroGenDx;.
has a financial relationship (Independent contractor) with Lilly;.
has a financial relationship (Independent contractor) with MicroGenDx;.
has a financial relationship (Independent contractor) with Lilly;.

Claus Roehrborn, MD

has a financial relationship (Independent contractor) with nymox;.
has a financial relationship (Other) with Protox;.
has a financial relationship (Other) with Procept Biorobotics;.
has a financial relationship (Independent contractor) with ZenFlow;.
has a financial relationship (Independent contractor) with Protox;.
has a financial relationship (Independent contractor) with Procept Biorobotics;.
has a financial relationship (Independent contractor) with Glaxo Smith Kline;.
has a financial relationship (Other) with Neotract;.
has a financial relationship (Other) with Astellas;.
has a financial relationship (Independent contractor) with Neotract;.
has a financial relationship (Independent contractor) with Boston Scientific;.

Steven Shichman, MD

has a financial relationship (Independent contractor) with Medtronic;.

Daniel Shoskes, MD

has a financial relationship (Independent contractor) with Farr Labs;.
has a financial relationship (Independent contractor) with Farr Labs;.

Jay Simhan, MD,FACS

has a financial relationship (Independent contractor) with Boston Scientific ;.
has a financial relationship (Independent contractor) with Coloplast;.
has a financial relationship (Independent contractor) with Boston Scientific ;.
has a financial relationship (Independent contractor) with Coloplast;.

Angela Smith, MD

has a financial relationship (Other) with AHRQ;.
has a financial relationship (Independent contractor) with Photocure;.
has a financial relationship (Other) with AHRQ;.
has a financial relationship (Independent contractor) with Photocure;.

Paul Turek, MD

has a financial relationship (Independent contractor) with Doximity, Inc;.
has a financial relationship (Independent contractor) with BioQuiddity, Inc;.
has a financial relationship (Independent contractor) with FutureFamily, Inc;.
has a financial relationship (Other Business Ownership) with Cellarity Biotechnologies, Inc;.
has a financial relationship (Independent contractor) with Medical Board of California;.
has a financial relationship (Independent contractor) with Contraline, Inc;.
has a financial relationship (Stock) with Cellarity Biotechnologies, Inc;.
has a financial relationship (Independent contractor) with MandalMed;.
has a financial relationship (Independent contractor) with DxNow, Inc;.
has a financial relationship (Stock) with Doximity, Inc;.
has a financial relationship (Stock) with BioQuiddity, Inc;.
has a financial relationship (Independent contractor) with Cellarity Biotechnologies, Inc;.

Robert Uzzo, MD,CEO,MBA

has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Other) with Genentech;.
has a financial relationship (Other) with Genentech;.
has a financial relationship (Other) with Novartis;.
has a financial relationship (Other) with Novartis;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Pfizer;.

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live and enduring activity for a maximum of 26.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

 


AUA PARTICIPANT INFORMATION & POLICIES

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

 
Status
Price
Title
$1,435.00Included
Please login or register to take this course.
$1,735.00Included
Please login or register to take this course.
$1,435.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Price:
$1,435.00
Please login or register to take this course.

NOTE:

  • Attendees may purchase the hard copy syllabus in addition to the Bundle (webcast + live course) OR Live course only.  
  • The printed syllabus is not availalbe for Webcast Only purchases. 
  • Attendees should not register for the Bundle (webcast + live course) in addition to the live course only or webcast only purchase option.

Early Bird Registration- On or before April 19, 2019

 

Live Course Only

Bundle (Live + Webcast)*

Webcast Only

Hard Copy Syllabus**

Now through May 10, 2019

Member$920$1220$920$205
Non-Member$1150$1450$1150
Member Resident/Allied$510$660$510
Non-Member Resident/Allied$635$785$635

 

Standard Registration- On or after April 20, 2019

 

 

Live Course Only

Bundle (Live + Webcast)*

Webcast Only

Hard Copy Syllabus**

Now through May 10, 2019

Member$1150$1450$920$205
Non-Member$1435$1735$1150
Member Resident/Allied$635$785$510
Non-Member Resident/Allied$790$940$635

*Includes registration for Annual Review Live Course and Webcast.

**Hard Copy syllabus is only for purchase for those attending the Live Course. No hard copy syllabus will be shipped.

Webcast will be available to view on Wednesday, June 5, 2019.


Cancellation Policy

Live Course

An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course.

Webcast

Cancellations must be made no later than one week prior to the live course. Subscription fees will not be refunded after the cancellation period. Purchases after the live course date are not eligible for a refund.

Registration Transfer

Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.

Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912. Questions? Call 1-800-908-9414 or email registration@AUAnet.org.

AUA Education & Research reserves the right to cancel this course if a minimum enrollment is not reached before May 3, 2019. If AUA Education & Research cancels this course, registration fees will be refunded in full and notification will be sent by May 10, 2019.